In addition, in animal model studies, the enhancement of the activity of low-density lipoprotein receptor-related protein-1 (LRP1) and the inhibition of the expression of erythrocyte integrin-related protein CD-47 can enhance endogenous hematoma clearance (Cao et al., 2016). The gene discussed is LRP1; the disease is hematoma.